Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesMechanisms of kidney fibrosis and the role of antifibrotic therapies
Current Opinion in Nephrology and Hypertension, 01/05/09
Deelman L et al. - Podocytes are recognized to play a key role in the development of kidney fibrosis. New antifibrotic therapies are rapidly progressing toward definitive clinical trials but will need to be tested on top of the existing therapy of renin-angiotensin system inhibition. Novel approaches targeting podocyte function would be a promising approach for early stages of the disease.
Related Articles
Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm
Current Opinion in Nephrology and Hypertension, 10/16/09
Relevance Score: 66%
Complement Activation and Progression of Chronic Kidney Disease
Hong Kong Journal of Nephrology, 10/07/09
Relevance Score: 66%
Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy
Pediatric Nephrology, 11/03/09
Relevance Score: 65%
Nephrogenic systemic fibrosis
Current Opinion in Rheumatology, 11/04/09
Relevance Score: 64%
UV-A1 Therapy for Nephrogenic Systemic Fibrosis
Archives of Dermatology, 10/21/09
Relevance Score: 64%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Physical Activity and Rapid Decline in Kidney Function Among Older Adults
Archives of Internal Medicine, 12/15/09
Chronic Calcineurin Inhibitor Nephrotoxicity: Reflections on an Evolving Paradigm
Clinical Journal of the American Society of Nephrology, 12/15/09
Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
Clinical Journal of the American Society of Nephrology, 12/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of Delayed Rapamycin Treatment on Renal Fibrosis and Inflammation in Experimental Ischemia Reperfusion Injury
Transplantation Proceedings, 12/15/09
Management of lupus nephritis - current perspectives
Indian Journal of Rheumatology , 12/15/09
Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
Clinical Journal of the American Society of Nephrology, 12/15/09
Article Search
Sponsor